Prime Medicine, Inc. Common Stock (PRME)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $932.06M
Last updated: Nov 17, 2026 at 4:31 PM ET
Prime Medicine, Inc. Common Stock (PRME) Stock Chart
Prime Medicine, Inc. Common Stock (PRME) has a latest price of $3.84 on Nov 17, 2026, 35.0% below its 52-week high of $5.91. Its price rose 13.9% over the past 12 months. The month-end price fell 27.3% over the 3 years through Oct 2026, a compound annual decline of 10.1%.
Price Chart
From Oct 2022 to Oct 2026, its highest month-end close was $18.82 in Oct 2022 and its lowest $1.18 in May 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart PRME with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PRME.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 8.5%, and over 6 months it rose 42.2%.
| Period | Change |
|---|---|
| 1 month | +0.3% |
| 3 months | +8.5% |
| 6 months | +42.2% |
| 12 months | +13.9% |
| 12 months, with dividends | +13.9% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -27.3% | -10.1% |
Price by Year
Its best calendar year was 2025, when the price rose 18.8%, and its weakest was 2024, when it fell 67.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $4.72 | +36.0% |
| 2025 | $3.47 | +18.8% |
| 2024 | $2.92 | -67.0% |
| 2023 | $8.86 | -52.3% |
Trading Range
The price is 3.4% above its 50-day average of $3.71 and 9.5% above its 200-day average of $3.51.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $3.84 | |
| 52-week high | $5.91 | -35.0% |
| 52-week low | $2.67 | +43.8% |
| 50-day average | $3.71 | +3.4% |
| 200-day average | $3.51 | +9.5% |
Price Risk
Over 3 years, its largest fall from a peak was 88.0%.
| Measure | Value |
|---|---|
| 1-year beta | 2.46 |
| Largest fall, 1 year | -42.2% |
| Largest fall, 3 years | -88.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About PRME
What is PRME's 1-year price change?
Prime Medicine, Inc. Common Stock's price rose 13.9% over the past 12 months. With dividends included, the 12-month total return was 13.9%.
How has PRME stock done over the long term?
Prime Medicine, Inc. Common Stock's month-end price fell 27.3% over the 3 years through Oct 2026, a compound annual decline of 10.1%. These figures leave out dividends.
What is PRME's 52-week high and low?
Prime Medicine, Inc. Common Stock's 52-week high is $5.91 and its 52-week low is $2.67. Its latest price of $3.84 on Nov 17, 2026 is 35.0% below the high.
What is PRME's beta?
Prime Medicine, Inc. Common Stock's 1-year beta against the S&P 500 is 2.46, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 42.2%.
Is the PRME chart free?
Yes. Advanced Charting for PRME is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
PRME pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors